Literature DB >> 22709488

Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis.

Xinyi Ng1, Julian Thumboo, Andrea H L Low.   

Abstract

AIMS: To perform cross-cultural adaptation and validation of the Scleroderma Health Assessment Questionnaire (S-HAQ) and Systemic Sclerosis Quality of Life scale (SSc-QoL) in English and Chinese-speaking patients with SSc.
METHODS: In this Institutional Review Board approved study, patients seen at the rheumatology outpatient clinics were consecutively recruited over a 10-month period. We evaluated: (i) test-retest reliability using the intraclass correlation coefficient (ICC); (ii) known-groups construct validity by stratifying patients according to organ involvement and symptom severity; and (iii) convergent validity using Spearman's correlation with Short Form 36 version 2 (SF36v2).
RESULTS: Forty-nine SSc patients completed the questionnaires: 26 Chinese, 23 English; 30 self-administered, 19 interviewer-administered, of which 35 responded to the retest. The SSc-QoL, HAQ Disability Index, intestinal Visual Analogue Scale (VAS), breathing VAS and overall disease severity VAS demonstrated high reliability (ICCs 0.71-0.93). The intestinal, finger ulcer and breathing S-HAQ VASs were able to differentiate patients according to their respective organ involvement. As hypothesized, the S-HAQ correlated better with the Physical Summary Component (PCS) than the Mental Summary Component (MCS) scores of the SF36v2. The SSc-QoL also demonstrated good convergent validity with the SF36v2 scales.
CONCLUSION: In this pilot study, we provided preliminary evidence to demonstrate the good test-retest reliability and reasonable construct validity of S-HAQ and SSc-QoL for use in English and Chinese-speaking SSc patients. This forms the basis for future studies to assess more extensively their psychometric properties.
© 2012 The Authors International Journal of Rheumatic Diseases © 2012 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22709488     DOI: 10.1111/j.1756-185X.2012.01731.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  2 in total

1.  Validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Singapore systemic sclerosis cohort.

Authors:  Andrea Hsiu Ling Low; Xiaohui Xin; Weng Giap Law; Gim Gee Teng; Amelia Santosa; Anita Lim; Grace Chan; Swee Cheng Ng; Julian Thumboo
Journal:  Clin Rheumatol       Date:  2017-01-05       Impact factor: 2.980

2.  Developing item banks to measure three important domains of health-related quality of life (HRQOL) in Singapore.

Authors:  Elenore Judy B Uy; Lynn Yun Shan Xiao; Xiaohui Xin; Joanna Peck Tiang Yeo; Yong Hao Pua; Geok Ling Lee; Yu Heng Kwan; Edmund Pek Siang Teo; Janhavi Ajit Vaingankar; Mythily Subramaniam; Mei Fen Chan; Nisha Kumar; Alcey Li Chang Ang; Dianne Carrol Bautista; Yin Bun Cheung; Julian Thumboo
Journal:  Health Qual Life Outcomes       Date:  2020-01-02       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.